14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Nov 20, 2023 Buy 585 366 Saxena Parag Pre-Funded Warrant
Nov 20, 2023 Buy 585 366 Saxena Parag Common Stock Warrant (right to buy)
Nov 13, 2023 Buy 8 200 Funtleyder Leslie D. Stock Option (right to buy)
Nov 13, 2023 Buy 8 200 Patel Purav Stock Option (right to buy)
Nov 13, 2023 Buy 8 200 Saxena Parag Stock Option (right to buy)
Apr 25, 2023 Buy 443 000 Bhat Laxminarayan Stock Option (right to buy)
Apr 25, 2023 Buy 150 000 Bhat Laxminarayan Stock Option (right to buy)
Apr 25, 2023 Buy 170 000 Narayan Prabhu Stock Option (right to buy)
Nov 18, 2022 Buy 3 000 Patel Purav Common Stock, par value $0.0001 per share
Nov 10, 2022 Buy 3 900 Saxena Parag Stock Option (right to buy)
Nov 10, 2022 Buy 3 900 Patel Purav Stock Option (right to buy)
Nov 10, 2022 Buy 3 900 Margolin Richard A Stock Option (right to buy)
Nov 10, 2022 Buy 3 900 Funtleyder Leslie D. Stock Option (right to buy)
Sep 30, 2022 Buy 50 000 Narayan Prabhu Common Stock, par value $0.0001 per share
Sep 08, 2022 Buy 869 565 Vedanta Partners, Llc Common Stock Warrant (right to buy)
Sep 08, 2022 Buy 869 565 Vedanta Partners, Llc Pre-Funded Warrant
Sep 08, 2022 Buy 513 834 Vedanta Partners, Llc Common Stock Warrant (right to buy)
Sep 08, 2022 Buy 513 834 Vedanta Partners, Llc Pre-Funded Warrant
Jun 30, 2022 Buy 50 000 Narayan Prabhu Common Stock, par value $0.0001 per share
Dec 08, 2021 Buy 5 300 Saxena Parag Stock Option (right to buy)
Dec 08, 2021 Buy 5 300 Patel Purav Stock Option (right to buy)
Dec 08, 2021 Buy 5 300 Margolin Richard A Stock Option (right to buy)
Dec 08, 2021 Buy 5 300 Funtleyder Leslie D. Stock Option (right to buy)
Jun 15, 2021 Buy 4 000 Saxena Parag Stock Option (right to buy)
Jun 15, 2021 Buy 4 000 Patel Purav Stock Option (right to buy)
Jun 15, 2021 Buy 4 000 Margolin Richard A Stock Option (right to buy)
Jun 15, 2021 Buy 4 000 Funtleyder Leslie D. Stock Option (right to buy)
Jun 01, 2021 Buy 931 000 Vedanta Partners, Llc Common Stock
Jun 01, 2021 Buy 931 000 Vedanta Partners, Llc Warrants (right to buy)
Jun 01, 2021 Buy 399 000 Vedanta Partners, Llc Common Stock
Jun 01, 2021 Buy 399 000 Vedanta Partners, Llc Warrants (right to buy)
Jun 01, 2021 Buy 0 Vedanta Partners, Llc Common Stock
Apr 14, 2021 Buy 50 000 Narayan Prabhu Stock Option (right to buy)
Apr 14, 2021 Buy 15 227 Patel Purav Stock Option (right to buy)
Dec 15, 2020 Sell 540 500 Tenzing Llc Warrants
Dec 14, 2020 Buy 197 500 Tenzing Llc Common Stock
Dec 14, 2020 Buy 197 500 Tenzing Llc Warrants
Dec 14, 2020 Buy 343 000 Tenzing Llc Warrants
Dec 14, 2020 Buy 0 Margolin Richard A
Dec 14, 2020 Buy 0 Patel Purav Common Stock
Dec 14, 2020 Buy 0 Patel Purav Common Stock
Dec 14, 2020 Buy 0 Patel Purav Common Stock
Dec 14, 2020 Buy 0 Parbhu Narayan
Dec 14, 2020 Buy 0 Cantillon Marc Common Stock
Dec 14, 2020 Buy 0 Cantillon Marc Common Stock
Dec 14, 2020 Buy 0 Funtleyder Leslie D.
Dec 14, 2020 Buy 0 Bhat Laxminarayan Common Stock
Dec 14, 2020 Buy 0 Bhat Laxminarayan Common Stock
Dec 08, 2020 Sell 367 000 Glazer Capital, Llc Ordinary Shares, no par value
Dec 08, 2020 Buy 0 Glazer Capital, Llc Ordinary Shares, no par value
Dec 08, 2020 Sell 710 000 Hudson Bay Capital Management Lp Ordinary Shares, no par value
Dec 07, 2020 Sell 50 000 Hudson Bay Capital Management Lp Ordinary Shares, no par value
Dec 03, 2020 Sell 606 360 Glazer Capital, Llc Ordinary Shares, no par value
Dec 02, 2020 Sell 261 Glazer Capital, Llc Ordinary Shares, no par value
Dec 01, 2020 Sell 5 362 Glazer Capital, Llc Ordinary Shares, no par value
Nov 27, 2020 Sell 5 969 Glazer Capital, Llc Ordinary Shares, no par value
Nov 24, 2020 Sell 7 103 Glazer Capital, Llc Ordinary Shares, no par value
Nov 23, 2020 Sell 23 611 Glazer Capital, Llc Ordinary Shares, no par value
Nov 18, 2020 Sell 896 Glazer Capital, Llc Ordinary Shares, no par value
Nov 17, 2020 Sell 127 Glazer Capital, Llc Ordinary Shares, no par value
Nov 16, 2020 Sell 305 Glazer Capital, Llc Ordinary Shares, no par value
Nov 11, 2020 Sell 5 Glazer Capital, Llc Ordinary Shares, no par value
Nov 06, 2020 Sell 1 Glazer Capital, Llc Ordinary Shares, no par value
Nov 03, 2020 Sell 57 616 Glazer Capital, Llc Ordinary Shares, no par value
Nov 02, 2020 Sell 1 Glazer Capital, Llc Ordinary Shares, no par value
Nov 02, 2020 Sell 50 000 Hudson Bay Capital Management Lp Ordinary Shares, no par value
Sep 29, 2020 Sell 2 Glazer Capital, Llc Ordinary Shares, no par value
Sep 17, 2020 Sell 1 000 Glazer Capital, Llc Ordinary Shares, no par value
Sep 14, 2020 Sell 1 Glazer Capital, Llc Ordinary Shares, no par value
Sep 01, 2020 Buy 0 Glazer Capital, Llc Ordinary Shares
May 08, 2020 Sell 51 000 Mizuho Securities Usa Llc Common Stock
May 07, 2020 Buy 0 Mizuho Securities Usa Llc Common Stock
Mar 20, 2020 Buy 10 000 Hudson Bay Capital Management Lp Ordinary Shares, no par value
Aug 30, 2018 Buy 33 000 Tenzing Llc Ordinary Shares
Aug 30, 2018 Buy 33 000 Nayar Rahul Ordinary Shares
Aug 30, 2018 Buy 33 000 Saxena Parag Ordinary Shares
Aug 23, 2018 Buy 310 000 Nayar Rahul Ordinary Shares
Aug 23, 2018 Buy 310 000 Saxena Parag Ordinary Shares
Aug 23, 2018 Buy 310 000 Tenzing Llc Ordinary Shares
Aug 21, 2018 Buy 0 Hudson Bay Capital Management Lp Ordinary Shares, par value $0.0001 per share
Aug 20, 2018 Buy 0 Saxena Parag Ordinary Shares
Aug 20, 2018 Buy 0 Nayar Rahul Ordinary Shares
Aug 20, 2018 Buy 0 Tenzing Llc Ordinary Shares
Aug 20, 2018 Buy 0 Campbell William I
Aug 20, 2018 Buy 0 Agarrwal Atanuu
Aug 20, 2018 Buy 0 Cordova Gonzalo
Aug 20, 2018 Buy 0 Thapar Vikas
Aug 20, 2018 Buy 0 Shapiro Nina B.
Dec 05, 2014 Buy 7 613 Cantillon Marc Stock Option
Dec 05, 2014 Buy 6 090 Bhat Laxminarayan Stock Option
Dec 05, 2012 Buy 30 453 Cantillon Marc Stock Option
INSIDER POWER
77.683
Last 91 transactions
Buy: 9 427 313 | Sell: 2 477 120 (Shares)

Based on the 91 latest insides trades, we have calculated the insider power to be positive at a ratio of 77.683.

In total, the insiders bought 9 427 313 and sold 2 477 120 RVPH shares in the last 91 trades.

Click to get the best stock tips daily for free!

About Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings. Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase... RVPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT